{"prompt": "['Date: June 30, 2020', 'Version: 8.0', 'Page: 4 of 52', '9.3.9', 'Stool samples', 'Error! Bookmark not defined.', '9.3.10', 'Breath gases', 'Error! Bookmark not defined.', '9.3.11', 'Adverse events', 'Error! Bookmark not defined.', '9.3.12', 'Pregnancies', 'Error! Bookmark not defined.', '9.3.13', 'Further safety', 'Error! Bookmark not defined.', '10. Data handling and quality assurance', 'Error! Bookmark not defined.', '10.1', 'Data recording', 'Error! Bookmark not defined.', '10.2', 'Monitoring', 'Error! Bookmark not defined.', '10.3', 'Data processing', 'Error! Bookmark not defined.', '10.3.1', 'Data collection', 'Error! Bookmark not defined.', '10.3.2', 'Data handling and quality assurance', 'Error! Bookmark not defined.', '10.4', 'Audit and inspection', 'Error! Bookmark not defined.', '10.5', 'Archiving', 'Error! Bookmark not defined.', '11. Premature termination of the study', 'Error! Bookmark not defined.', '12. Ethical and legal aspects', 'Error! Bookmark not defined.', '12.1', 'Ethical and legal conduct of the study', 'Error! Bookmark not defined.', '12.2', 'Patient information and consent', 'Error! Bookmark not defined.', '12.3', 'Publication policy', 'Error! Bookmark not defined.', '12.4', 'Confidentiality', 'Error! Bookmark not defined.', '13. Appendices', 'Error! Bookmark not defined.', '13.1', 'Laboratory tests', 'Error! Bookmark not defined.', '13.2', 'Bristol stool chart', 'Error! Bookmark not defined.', '13.3', 'Daily questionnaire', 'Error! Bookmark not defined.', '13.4', 'PAC-SYM', 'Error! Bookmark not defined.', '13.5', 'Quality of life questionnaire', 'Error! Bookmark not defined.', '13.6', 'Medical history', 'Error! Bookmark not defined.', '14. References', 'Error! Bookmark not defined.']['Date: June 30, 2020', 'Version: 8.0', 'Page: 5 of 52', '1. Project summary', 'Compound No.', 'Name of Active Ingredient of', 'SYN-010 lovastatin lactone modified release capsules', 'Investigational Agent', 'Route of Administration', '21mg given orally once daily', '42mg given orally once daily', 'Title of Study', 'Evaluation of the EfficAcy and Safety of SinglE, Daily Oral Doses of', 'SYN-010 Compared to Placebo in Adult Patients with Irritable Bowel', 'Syndrome with Constipation (EASE-DO)', 'Study Center', 'Cedars-Sinai Medical Center', '8700 Beverly Boulevard', 'Los Angeles, CA 90048', 'Phase of Clinical Development', 'Phase II', 'Indication', 'Irritable Bowel Syndrome with Constipation (IBS-C)', 'Control Agent', 'Reference product is Placebo in matching presentation to be given', 'Name of Active Ingredient of', 'orally once-daily.', 'Control Agent', 'Route of Administration', 'Clinical Study Phase', 'Phase Il', 'Study Objectives', 'Primary:', 'Change from baseline in the weekly average number of CSBMs during', 'the 12-week Treatment Period for SYN-010 relative to placebo.', 'Secondary:', 'Safety and tolerability of SYN-010 21 mg and 42 mg in IBS-C patients', 'treated for 12 weeks.', 'For SYN-010 relative to placebo:', 'Proportion of overall stool frequency responders.', 'Proportion of overall bloating responders.', 'Proportion of patients using rescue medication.', 'Proportion of overall responders in the SYN-010 21 mg and 42', 'mg treatment groups versus placebo.', 'Change from baseline for SYN-010, relative to placebo, in:', 'Weekly average score for worst abdominal pain at Weeks', '1 through 12.', 'Weekly average number of CSBMs at Weeks 1 through', '12.', 'Weekly average number of SBMs at Weeks 1 through 12.', 'Weekly average bloating score at Weeks 1 through 12.', 'Weekly average stool consistency (BSFS) at Weeks 1', 'through 12.', 'Exploratory:', 'For SYN-010 relative to placebo:', 'Proportion of patients with adequate relief.']\n\n###\n\n", "completion": "END"}